MRC1 and neoplasm: As observed originally, the absence of MMR defects appeared to exclude breast cancer as an integral tumor of LS [14] whereas subsequent studies report the occurrence of MMR defects in breast carcinomas from MMR gene mutation carriers with frequencies ranging between 44% and 75% based on MSI and/or aberrant MMR protein expression [8,15-19].